Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 1, 2006, Pages 204-212

  Hoffmann, K Martin ^a   Gibril, Fathia ^a   Entsuah, Laurence K ^a   Serrano, Jose ^a   Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CORRELATION ANALYSIS; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS DISEASE; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; GASTRINOMA; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HIATUS HERNIA; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; MANOMETRY; MULTIPLE ENDOCRINE NEOPLASIA; OUTCOME ASSESSMENT; PATHOGENESIS; PRECANCER; PRIORITY JOURNAL; RISK FACTOR; TERTIARY HEALTH CARE; ZOLLINGER ELLISON SYNDROME;

ADULT; BARRETT ESOPHAGUS; ESOPHAGEAL DISEASES; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGEAL STENOSIS; ESOPHAGOSCOPY; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTRINOMA; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PROSPECTIVE STUDIES; RISK; SEX FACTORS; ZOLLINGER-ELLISON SYNDROME;

EID: 30344484225     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1349     Document Type: Article

References (61)

1. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA 1998 Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129:484-494
2. Gibril F, Schumann M, Pace A, Jensen RT 2004 Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. A prospective study of 107 cases and comparison with 1009 patients from the literature. Medicine 83:43-83
3. Jensen RT 1998 Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 243:477-488
4. Gibril F, Venzon DJ, Ojeaburu JV, Bashir S, Jensen RT 2001 Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab 86:5282-5293
5. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT 2001 Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 234:495-506
6. Jensen RT 2001 Zollinger-Ellison syndrome. In: Doherty GM, Skogseid B, eds. Surgical endocrinology: clinical syndromes. Philadelphia: Lippincott, Williams, Wilkins; 291-344
7. Roy P, Venzon DJ, Feigenbaum KM, Koviack PD, Bashir S, Ojeaburu JV, Gibril F, Jensen RT 2001 Gastric secretion in Zollinger-Ellison syndrome: correlation with clinical expression, tumor extent and role in diagnosis - a prospective NIH study of 235 patients and review of the literature in 984 cases. Medicine(Baltimore) 80:189-222
8. Roy P, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT 2000 Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine 79:379-411
9. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F, Jensen RT 1999 Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341:635-644
10. Norton JA, Cornelius MJ, Doppman JL, Maton PN, Gardner JD, Jensen RT 1987 Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome and multiple endocrine neoplasia type I: a prospective study. Surgery 102:958-966
11. McCarthy DM, Peikin SR, Lopatin RN, Long BW, Spiegel A, Marx S, Brennan M 1979 Hyperparathyroidism a reversible cause of cimetidine-resistant gastric hypersecretion. Br Med J 1:1765-1766
12. Danielides IC, Mellow MH 1978 Effect of acute hypercalcemia on human esophageal motility. Gastroenterology 75:1115-1119
13. Mowschenson PM, Rosenberg S, Pallota J, Silen W 1982 Effect of hyperparathyroidism and hypercalcemia on lower esophageal sphincter pressure. Am J Surg 143:36-39
14. Thompson NW 1998 Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 243:495-500
15. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, Gibril F, Metz DC, Fraker DL, Norton JA, Jensen RT 1995 Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108:1637-1649
16. Jensen RT 1999 Use of omeprazole and other proton pump inhibitors in the Zollinger-Ellison syndrome. In: Olbe L, ed. Milestones in drug therapy. Basel, Switzerland: Birkhauser Verlag AG Publishing Co.; 205-221
17. Miller LS, Vinayek R, Frucht H, Gardner JD, Jensen RT, Maton PN 1990 Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 98:341-346
18. Metz DC, Pisegna JR, Fishbeyn VA, Benya RV, Feigenbaum KM, Koviack PD, Jensen RT 1992 Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high. Gastroenterology 103:1498-1508
19. Bondeson AG, Bondeson L, Thompson NW 1990 Stricture and perforation of the esophagus: overlooked threats in the Zollinger-Ellison syndrome. World J Surg 14:361-363
20. Kahn H, Waxman J 1992 Peripancreatic lymph node gastrinoma in a patient with Zollinger-Ellison syndrome. Mt Sinai J Med 59:425-428
21. Ng T, Maziak DE, Shamji FM 2001 Esophageal perforation: a rare complication of Zollinger-Ellison syndrome. Ann Thorac Surg 72:592-593
22. Symonds DA, Ramsey HE 1980 Adenocarcinoma arising in Barrett's esophagus with Zollinger-Ellison syndrome. Am J Clin Pathol 73:823-826
23. Spechler SJ 2003 Esophageal complications of gastroesophageal reflux disease: presentation, diagnosis, management, and outcomes. Clin Cornerstone 5:41-48
24. Flejou JF 2005 Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut 54(Suppl 1):i6-i12
25. Richter JE 1999 Peptic strictures of the esophagus. Gastroenterol Clin North Am 28:875-891
26. Richter JE, Pandol SJ, Castell DO, McCarthy DM 1981 Gastroesophageal reflux disease in the Zollinger-Ellison syndrome. Ann Intern Med 95:37-43
27. Kark TR, Pindyck F, Sicular A 1983 Zollinger-Ellison syndrome with esophagitis and barrett mucosa. Am J Gastroenterol 78:611-614
28. Ramakrishnan T 1981 Zollinget-Ellison syndrome presenting as reflux esophagitis and stricture. J La State Med Soc 133:189-190
29. Smith HJ, Chapa HJ, Kilman WJ, Watkins WL 1979 Zollinger-Ellison syndrome presenting as esophageal stricture. Gastrointest Radiol 4:349-351
30. Fishbeyn VA, Norton JA, Benya RV, Pisegna JR, Venzon DJ, Metz DC, Jensen RT 1993 Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach. Ann Intern Med 119:199-206
31. Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, Jensen RT 1994 Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med 97:436-444
32. Termanini B, Gibril F, Reynolds JC, Doppman JL, Chen CC, Stewart CA, Sutliff VE, Jensen RT 1997 Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology 112:335-347
33. Frucht H, Doppman JL, Norton JA, Miller DL, Dwyer AJ, Frank JA, Vinayek R, Maton PN, Jensen RT 1989 Gastrinomas: comparison of MR imaging with CT, angiography and US. Radiology 171:713-717
34. Maton PN, Miller DL, Doppman JL, Collen MJ, Norton JA, Vinayek R, Slaff JI, Wank SA, Gardner JD, Jensen RT 1987 Role of selective angiography in the management of Zollinger-Ellison syndrome. Gastroenterology 92:913-918
35. Gibril F, Chen Y-J, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, Asgharian B, Jensen RT 2003 Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88:1066-1081
36. Gibril F, Reynolds JC, Chen CC, Yu F, Goebel SU, Serrano J, Doppman JL, Jensen RT 1999 Specificity of somatostatin receptor scintigraphy: a prospective study and the effects of false positive localizations on management in patients with gastrinomas. J Nucl Med 40:539-553
37. Asgharian B, Chen YJ, Patronas NJ, Peghini PL, Reynolds JC, Vortmeyer A, Zhuang Z, Venzon DJ, Gibril F, Jensen RT 2004 Meningiomas may be a component tumor of MEN1. Clin Cancer Res 10:869-880
38. Gibril F, Reynolds JC, Roy PK, Peghini PL, Doppman JL, Jensen RT 2000 Ability of somatostatin receptor scintigraphy to identify patients with localized gastric carcinoids: a prospective study. J Nucl Med 41:1646-1656
39. Sheppard BC, Norton JA, Doppman JL, Maton PN, Gardner JD, Jensen RT 1989 Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery 106:1108-1117
40. Collen MJ, Howard JM, McArthur KE, Raufman JP, Cornelius MJ, Ciarleglio CA, Gardner JD, Jensen RT 1984 Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med 100:52-58
41. Raufman JP, Collins SM, Pandol SJ, Korman LY, Collen MJ, Cornelius MJ, Feld MK, McCarthy DM, Gardner JD, Jensen RT 1983 Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. Gastroenterology 84:108-113
42. Maton PN, Frucht H, Vinayek R, Wank SA, Gardner JD, Jensen RT 1988 Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study. Gastroenterology 94:294-299
43. Maton PN, Vinayek R, Frucht H, McArthur KA, Miller LS, Saeed ZA, Gardner JD, Jensen RT 1989 Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology 97:827-836
44. Asgharian B, Turner ML, Gibril F, Entsuah LK, Serrano J, Jensen RT 2004 Cutaneous tumors in patients with MEN1 and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity. J Clin Endocrinol Metab 89:5328-5336
45. Strader DB, Benjamin S, Orbuch M, Lubensky TA, Gibril F, Weber C, Fishbeyn VA, Jensen RT, Metz DC 1995 Esophageal function and occurrence of Barrett's esophagus in Zollinger-Ellison syndrome. Digestion 56:347-356
46. Sampliner RE 1998 Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus, the Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93:1028-1032
47. Eloubeidi MA, Provenzale E 2001 Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 33:306-309
48. Lieberman DA, Oehlke M, Helfand M 1997 Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 92:1293-1297
49. Castell DO, Wu WC, Ott DJ 1985 Gastroesophageal reflux disease. Mount Kisco, NY: Futura; 1-324
50. Sachithanandan N, Harle RA, Burgess JR 2005 Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer 103:509-515
51. Coenraad M, Masclee AA, Straathof JW, Ganesh S, Griffioen G, Lamers CB 1998 Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis? Am J Gastroenterol 93:1068-1072
52. Hirschowitz BI, Simmons JL, Johnson LF, Mohnen J 2004 Risk factors for esophagitis in extreme acid hypersecretors with and without Zollinger-Ellison syndrome. Clin Gastroenterol Hepatol 2:220-229
53. Liu DH, Crastnopol P, Phillips W 1967 Perforation of a gastrojejunal ulcer into the pericardium. Arch Surg 94:294-298
54. Toruner M, Soykan I, Ensari A, Kuzu I, Yurdaydin C, Ozden A 2004 Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol 19:535-540
55. Csendes A, Smok G, Quiroz J, Burdiles P, Rojas J, Castro C, Henriquez A 2002 Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol 97:554-560
56. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK 1994 Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 344:1533-1536
57. Weston AP, Sharma P, Mathur S, Banerjee S, Jafri AK, Cherian R, McGregor D, Hassanein RS, Hall M 2004 Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 99:1657-1666
58. Wakelin DE, Al-Mutawa T, Wendel C, Green C, Garewal HS, Fass R 2003 A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 58:350-355
59. Cameron AJ 1999 Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 94:2054-2059
60. Loughney T, Maydonovitch CL, Wong RK 1998 Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus. Am J Gastroenterol 93:916-919
61. 2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology 88:1026-1033